ArticleInternational journal of colorectal disease2019

ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials.

Omar Abdel-RahmanPubMed ↗Publisher ↗

No numbers read from the abstract.